AB AEON Biopharma, Inc. Stock: price and insider trades · United States · SEC (Form 4)Track the AEON Biopharma, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €12.2m. The latest transaction was filed on 21 August 2026 (Acquisition). Among the most active insiders: FISCHER JOST. Every trade is free.
Analyst consensus: bullish or bearish? Analysts rate AEON Biopharma, Inc. Strong Buy (bullish), based on 3 analysts. Average price target: US$1.43.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 21 August 2026
All Executives25 Thresholds0 Prospectus0 Other0
Declarations 25 total
▲ 10% Owner · Executives · 19 Aug 2026
1,150,000 shares @ US$0.2117 Class A Common Stock SEC:0000935836-26-000440:0
Canonical exit: 17 Nov 2026 (T+90) ◆ Director · Executives · 17 Jun 2026
222,684 shares Class A Common Stock SEC:0001104659-26-076509:0
◆ Director · Executives · 17 Jun 2026
222,684 shares Class A Common Stock SEC:0001104659-26-076510:0
◆ Director · Executives · 17 Jun 2026
222,684 shares Class A Common Stock SEC:0001104659-26-076511:0
◆ Director · Executives · 17 Jun 2026
222,684 shares Class A Common Stock SEC:0001104659-26-076513:0
◆ Director · Executives · 17 Jun 2026
222,684 shares Class A Common Stock SEC:0001104659-26-076515:0
◆ CHIEF FINANCIAL OFFICER · Executives · 2 Apr 2026
754,717 shares 0Class A Common Stock SEC:0001104659-26-039697:0
◆ CHIEF MEDICAL OFFICER · Executives · 17 Feb 2026
862,500 shares 0Class A Common Stock SEC:0001104659-26-026550:0
◆ CLO, CSO, and Corp Secretary · Executives · 17 Feb 2026
862,500 shares 0Class A Common Stock SEC:0001104659-26-024233:0
◆ PRINCIPAL ACCOUNTING OFFICER · Executives · 17 Feb 2026
575,000 shares 0Class A Common Stock SEC:0001104659-26-024231:0
◆ PRESIDENT & CEO · Executives · 17 Feb 2026
3,000,000 shares 0Class A Common Stock SEC:0001104659-26-017726:0
▲ Director · Executives · 21 May 2025
60,000 shares @ US$0.4875 53.8% of flow Class A Common Stock SEC:0001610717-25-000129:0
Canonical exit: 19 Aug 2025 (T+90) ▲ Director · Executives · 19 May 2025
50,000 shares @ US$0.4988 46.2% of flow Class A Common Stock SEC:0001610717-25-000124:0
Canonical exit: 17 Aug 2025 (T+90) ◆ President & CEO · Executives · 14 May 2025
177,103 shares 0Class A Common Stock SEC:0001610717-25-000120:0
◆ Director · Executives · 31 Aug 2024
36,021 shares 0Class A Common Stock SEC:0001104659-24-098707:0
◆ Director · Executives · 31 Aug 2024
36,021 shares 0Class A Common Stock SEC:0001104659-24-097059:0
◆ CHIEF MEDICAL OFFICER · Executives · 31 Aug 2024
192,117 shares 0Class A Common Stock SEC:0001104659-24-097064:0
◆ Director · Executives · 31 Aug 2024
36,021 shares 0Class A Common Stock SEC:0001104659-24-097065:0
◆ Director · Executives · 31 Aug 2024
36,021 shares 0Class A Common Stock SEC:0001104659-24-097061:0
◆ CHIEF EXECTUIVE OFFICER · Executives · 31 Aug 2024
470,692 shares 0Class A Common Stock SEC:0001104659-24-097067:0
◆ PRINCIPAL ACCOUNTING OFFICER · Executives · 31 Aug 2024
18,010 shares 0Class A Common Stock SEC:0001104659-24-097062:0
◆ Director · Executives · 31 Aug 2024
36,021 shares 0Class A Common Stock SEC:0001104659-24-097060:0
◆ EXEC VP, CLO & CORP SECRETARY · Executives · 31 Aug 2024
180,110 shares 0Class A Common Stock SEC:0001104659-24-097066:0
6,900,000 shares Class A Common Stock SEC:0000950103-23-010810:0
◆ Director · Executives · 21 Jul 2023
13,274 shares Class A Common Stock SEC:0001104659-23-083565:0
About AEON Biopharma, Inc. AEON Biopharma, Inc. is a company focused on developing biopharmaceutical treatments. It is listed on the XNAS market.